Skip to content
Back to SILO

Silo Pharma, Inc.

Open-market purchases and sales reported on SEC Forms 4 and 5, with each filing and its footnotes.

Since Nov 18, 2025
Transactions
6
Purchases
6
Sales
0
Purchase value
$7.66K
Sale value
$0.00

Values are shares multiplied by reported price when both were supplied, each trade counted once however many filers reported it.

Eric WeisblumDirector · Chief Executive Officer
4
Filed Dec 16, 2025Period of report Dec 15, 20250001213900-25-122429
TransactionSecuritySharesPriceValueHeld afterOwnership
PurchaseDec 15, 2025
Common Stock2,500$0.41$1.03K214,432Direct
PurchaseDec 15, 2025
Common Stock2,500$0.42$1.05K216,932Direct
Open on SEC EDGAR
Eric WeisblumDirector · Chief Executive Officer
4
Filed Nov 21, 2025Period of report Nov 20, 20250001213900-25-113743
TransactionSecuritySharesPriceValueHeld afterOwnership
PurchaseNov 21, 2025
Common Stock1,000$0.365$365.00211,932Direct
PurchaseNov 20, 2025
Common Stock1,000$0.37$370.00210,932Direct
Open on SEC EDGAR
Eric WeisblumDirector · Chief Executive Officer
4
Filed Nov 20, 2025Period of report Nov 18, 20250001213900-25-113104
TransactionSecuritySharesPriceValueHeld afterOwnership
PurchaseNov 19, 2025
Common StockF24,500$0.405$1.82K209,932Direct
PurchaseNov 18, 2025
Common StockF17,500$0.4033$3.02K205,432Direct
Filing footnotes · 2
  1. F1This price reflects the weighted average price at which these shares were purchased. The shares were purchased in multiple transactions on November 18, 2025 at prices ranging from $0.4000 to $0.4050. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
  2. F2This price reflects the weighted average price at which these shares were purchased. The shares were purchased in multiple transactions on November 19, 2025 at prices ranging from $0.3975 to $0.4100. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
Open on SEC EDGAR

P and S transaction codes only. Grants, gifts, option exercises, tax withholding, and Form 144 notices are not counted as purchases or sales. A row whose filed price fails a plausibility check, or that is not common stock, is listed but left out of the values; a trade reported by several filers is counted once.